Nephrology and Urology Devices

miR Scientific announces commercial launch of miR Sentinel

miR Scientific has announced the commercial launch of its miR Sentinel Prostate Cancer Test in the US, Puerto Rico and…

Elypta raises funds to develop multi-cancer early detection test

Swedish diagnostics firm Elypta has raised $21m in a Series A financing round for the development of a metabolism-based multi-cancer…

Vibrant Gastro reports positive data from drug-free CIC treatment trial

Vibrant Gastro has announced positive Phase III study results of its drug-free treatment for chronic idiopathic constipation (CIC) in adult…

Quanta secures $245m to market haemodialysis system

Quanta Dialysis Technologies has raised $245m in a Series D funding round led by Glenview Capital to expedite the marketing…

Biocept and Quest Diagnostics partner on lung cancer biopsy test

Biocept has partnered with Quest Diagnostics to offer its Target Selector next-generation sequencing (NGS)-based liquid biopsy targeted lung cancer panel…

Novo Holdings acquires BBI Group from Exponent for $564m

Novo Holdings has acquired diagnostic products and services supplier, BBI Group, from Exponent for an enterprise value of more than…

Olympus acquires Israeli medical device firm Medi-Tate 

Olympus has acquired Israeli medical device company Medi-Tate to enhance its business portfolio for in-office treatment of benign prostatic hyperplasia…

BD treats first subjects in study of WavelinQ system for fistula creation

Becton, Dickinson and Company (BD) has treated the first subjects with the WavelinQ EndoAVF System in a post-market surveillance study…

CLEP approves biomarker assays from Eurofins and Transplant Genomics

The New York State Department of Health Clinical Laboratory Evaluation Program (CLEP) has approved two non-invasive tests from Eurofins Viracor…

Vagus nerve stimulation sheds light on tackling obesity

For most people, and to their frustration, putting on weight is much easier than shedding pounds. But obesity is not…